December 2019 update – Evolution Mining share price drops

Gold miner Evolution Mining Limited (ASX:EVN) reported its December 2019 quarter update to investors today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Evolution Mining Limited (ASX: EVN) reported its December 2019 quarter update to investors today.

The gold miner reported mine operating cash flow of $233.1 million, the FY20 year to date figure is $511.8 million. Net mine cash flow was $144.4 million, the FY20 year to date was total is $351.8 million. 

Evolution Mining reported group free cash flow of $83.8 million with the FY20 year to date figure being $242.4 million. 

As a result of the strong cash flow Evolution Mining was able to repay $275 million of outstanding debt and the net cash position increased by $78.6 million to $170.3 million. 

In terms of production the company produced 170,890 ounces of gold at an all-in sustaining cost (AISC) of AU$1,069 per ounce (which was US$730 per ounce in US dollar terms). That brings the FY20 year to date production to 362,857 ounces at an ASIC of AU$1,041 per ounce, or US$713 per ounce. 

During the quarter Evolution Mining made an acquisition of the high grade, long life Red Lake gold complex in Ontario, Canada, which is expected to close at the end of March 2020. 

Evolution Mining said that Cowal's GRE46 and Dalwhinnie ore bodies continue to return "exceptional" drilling results which is expected to inform an upgrade in size and classification of the current underground mineral resource of 1.4 million ounces. The Board has approved the commencement of a pre-feasibility mine design study for an underground mine.

Evolution Mining's guidance remains unchanged, it's expecting FY20 gold production to be around 725,000 ounces with an AISC of AU$940 to AU$990 per ounce.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Rising ASX uranium share price icon on a stock index board.
Broker Notes

Why ASX uranium shares like Paladin and Boss Energy could be set to rocket

A top broker expects Boss Energy, Paladin, and these three ASX uranium stocks to outperform. But why?

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Broker names 3 ASX 200 shares to buy in March

Let's see why these shares are being tipped as buys this month.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

Investors caught a break with a decent recovery from the markets today.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Why this cheap ASX 200 stock could rise 80%

Bell Potter thinks this stock could be destined to surge.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why BHP, EQ Resources, Lottery Corp, and Woodside shares are falling today

These shares are struggling on Thursday. Let's find out why.

Read more »

Happy work colleagues give each other a fist pump.
Share Gainers

Why Endeavour, Lindian, Magellan, and WiseTech shares are storming higher today

These shares are catching the eye on Thursday. Let's see why they are rising.

Read more »

Man on a laptop thinking.
Broker Notes

Buy, hold, sell: Endeavour, Life360, and Lynas shares

Let's see what the broker is saying about these shares this week.

Read more »

A doctor looks unsure.
Opinions

3 reasons why the CSL share price could leap 87% to $274!

Here's what to expect from the Biotech stock next.

Read more »